InvivoGen Insight Newsletters
- Review: Improving the efficacy of clinical antibodies
Monoclonal antibodies (mAbs) have shown considerable success as cancer therapeutics and the number of anticancer mAbs in clinical use or under investigation has dramatically increased in recents years. However, there remains much room for improvement. Therapeutic antibodies act mainly by directly targeting tumor cells or by targeting immune cells in the tumor microenvironment....
Mycoplasma removal agent
High quality ready-to-use selective antibiotics with purity levels exceeding 95%.
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2015 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".